How much funding has Sapience Therapeutics Inc. raised?

Sapience Therapeutics Inc. has raised $4.0M in total funding, most recently a Grant round.

Who are Sapience Therapeutics Inc.'s investors?

Sapience Therapeutics Inc.'s investors include National Cancer Institute, National Institute of Allergy and Infectious Diseases.

When was Sapience Therapeutics Inc. founded?

Sapience Therapeutics Inc. was founded in 2020.

Where is Sapience Therapeutics Inc. headquartered?

Sapience Therapeutics Inc. is headquartered in Harrison, New York, United States.

What industry is Sapience Therapeutics Inc. in?

Sapience Therapeutics Inc. operates in Biotech, Healthcare.

How many employees does Sapience Therapeutics Inc. have?

Sapience Therapeutics Inc. has 1-10 employees.

Sapience Therapeutics Inc.

Changing the tide to achieve the unachievable

Harrison, United States · Founded 2020 · $4.0M raised

Biotech

Healthcare

Headquarters: Harrison, New York
Employees: 1–10
Founded: 2020
Business Model: B2G

Website: sapiencetherapeutics.com
Total Funding: $4.0M
Last Round: $632K GrantJan 2024
Rounds: 5

About

Sapience Therapeutics is a clinical-stage oncology company developing precision peptide therapeutics using its SPEARs™ and SPARCs™ platforms that target intracellular and extracellular protein-protein interactions. Its lead programs, lucicebtide (ST101) and ST316, are in Phase 2 trials for glioblastoma, melanoma, and colorectal cancer.

Summary

Sapience Therapeutics Inc. is a Biotech company based in Harrison, United States, founded in 2020. It has raised $4.0M in total across 5 rounds, most recently a $632K Grant round in Jan 2024. Investors include National Cancer Institute and National Institute of Allergy and Infectious Diseases.